Clinical Trial Update: Vagal Blocking for Obesity Control [NA]

View source ↗

Summary

Clinical trial update on vagal blocking for obesity control by ReShape Lifesciences; status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: ReShape Lifesciences | Conditions: Obesity | NA | Status: UNKNOWN